Fetal growth restriction (FGR) is a significant concern in obstetrics, affecting 5–10% of pregnancies globally. FGR is a major contributor to perinatal morbidity and mortality
16 October 2024 | Indica Labs is pleased to announce our Bay Area HALO® User Group Meeting at the AC Hotel San Francisco Airport / Oyster Point Waterfront on October 16 from 9:00 am – 4:50 pm. Lunch will be provided to all pre-registered attendees at 12:30 pm.
Indica Labs’ Bay Area HALO® 2024 User Group Meeting Read More »
As laboratories work to fulfill their data integrity requirements, digital pathology adoption can significantly streamline workflows and improve the accuracy and depth of recorded data. In this blog post, we share how the new Compliance Add-on available in HALO Link 4.0 can help laboratories promote data best practices through auditing and reporting.
HALO Link Compliance Add-on: Promoting Best Practices in Digital Pathology Laboratories Read More »
Albuquerque, NM – 2 July 2024 – Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.
Albuquerque, NM – 23 May 2024 – Indica Labs, the global leader in AI-powered digital pathology solutions, announced today the release of the transformative new version of its industry-leading life sciences software.
16 May 2024 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 16 from 1 pm – 5 pm. A lunch will be provided to all pre-registered attendees at 12 pm.
Indica Labs’ Boston HALO® User Group Meeting Read More »
6 June 2024 | Join us for this 1-hour webinar to see a live demonstration of the new versions of the industry leading AI-powered HALO® and HALO AI digital pathology image analysis platform and the HALO Link collaborative image management platform.
AI-Powered Pathology with HALO®, HALO AI, and HALO Link 4.0 Read More »
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist of AI Collaborations at Indica Labs, will present case studies of customer collaborations resulting in the development and validation of commercially available and inter-operable AI algorithms addressing customer needs.
13 March 2024 | Indica Labs is pleased to announce our Frankfurt HALO® User Group Meeting at Hyatt Place Frankfurt Airport Hotel on 13 March from 12:00 – 18:00.
Indica Labs’ Frankfurt HALO® User Group Meeting Read More »
As we welcome the new year and look back on 2023, the Indica Labs team wants to extend our heartfelt thanks to our customers and collaborators. We feel privileged to have been a part of our customers’ impactful contributions in the lab and clinic, and it is thrilling to hear of their successes improving patient care as well as our understanding and treatment of disease.
Looking Back: Reviewing 2023 at Indica Labs Read More »
